13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001104659-25-112503
Total Value
$108.7M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG Oncology, Inc. | CGON | 1,004,050 | $40.4M | 37.19% |
| 2 | ALUMIS INC. | ALMS | 5,779,348 | $23.1M | 21.21% |
| 3 | Disc Medicine, Inc. | IRON | 299,069 | $19.8M | 18.17% |
| 4 | Hims & Hers Health, Inc. | HIMS | 273,151 | $15.5M | 14.25% |
| 5 | Lyell Immunopharma, Inc. | LYEL | 477,078 | $7.7M | 7.12% |
| 6 | Maze Therapeutics, Inc. | MAZE | 86,291 | $2.2M | 2.06% |